PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 27 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

21 November 2025

  1. (diff | hist) 18:21 Syringe dead space 12,801 +1,645 MicrodoseMagnus (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  2. (diff | hist) 12:32 Certificate of analysis 10,014 ±0 LotTraceLuka (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  3. (diff | hist) 08:16 Fasting insulin 4,198 ±0 UACR_Ulric (talk | contribs) typo [rollback]
  4. (diff | hist) 07:18 SUSTAIN trial programme 5,153 ±0 CagriCass (talk | contribs) state that the trial has reported but is not yet peer-reviewed [rollback]
  5. (diff | hist) 06:32 Peptide aggregation 5,516 ±0 KarlFischerKit (talk | contribs) expand §Detection [rollback]
  6. (diff | hist) 05:15 Prior authorisation 4,216 ±0 HarmReductionHen (talk | contribs) add the manufacturer assistance programme with its eligibility criterion [rollback]
  7. (diff | hist) m 01:50 Baseline laboratory panel 4,429 ±0 ApoB_Aurelio (talk | contribs) attribute the population interval to the cohort it was derived from [rollback]
  8. (diff | hist) m b 01:09 Drug master file 4,325 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]

20 November 2025

  1. (diff | hist) 21:01 Cagrilintide 4,256 ±0 NeutralNikolai (talk | contribs) expand §Material sold under the name [rollback]
  2. (diff | hist) 20:21 Cold chain 26,583 ±0 LCellLeif (talk | contribs) correct the eutectic temperature — source gives a range [rollback]
  3. (diff | hist) 20:12 Aspiration risk under anaesthesia 4,681 ±0 SarcopeniaSefa (talk | contribs) expand §Interpretation [rollback]
  4. (diff | hist) 17:17 Dose escalation schedule 4,993 ±0 SyringeSybille (talk | contribs) expand §Deviations and their consequences [rollback]
  5. (diff | hist) 15:01 Arcuate nucleus 5,251 ±0 ArcuateArt (talk | contribs) typo [rollback]
  6. (diff | hist) m 12:50 Third-party testing 7,489 ±0 TimelineTiernan (talk | contribs) ce, tighten prose [rollback]
  7. (diff | hist) m b 12:38 Temperature excursion 19,692 +1,146 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  8. (diff | hist) 07:55 Talk:Glucagon-like peptide-1 885 +147 Chromatokid (talk | contribs) /* Is the "50–75% degraded before leaving the gut" figure attributable? */ reply
  9. (diff | hist) m b 05:47 Qingdao Saber Technology Pharmaceutical 10,522 +1,387 CiteBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) 01:08 STEP trial programme 5,534 ±0 TrialsTabitha (talk | contribs) add the confidence interval to the point estimate [rollback]
  11. (diff | hist) 00:22 Enteroendocrine L cell 5,083 ±0 SatietySunniva (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]

19 November 2025

  1. (diff | hist) 16:45 Grey market 4,279 +211 AnalyticalAnnie (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  2. (diff | hist) 16:29 SURMOUNT trial programme 5,021 ±0 SurpassSunniva (talk | contribs) add the run-in period, which changes how the baseline reads [rollback]
  3. (diff | hist) 16:20 Talk:Glucagon-like peptide-1 674 +321 CitationChaser (talk | contribs) /* Is the "50–75% degraded before leaving the gut" figure attributable? */ new section
  4. (diff | hist) m 15:52 Loss on drying 4,874 ±0 SigFigSindri (talk | contribs) add the repeatability figure with the number of injections [rollback]
  5. (diff | hist) 15:38 Prescribing information 4,506 ±0 PatientPanelPru (talk | contribs) add the harm-reduction cross-link [rollback]
  6. (diff | hist) m 15:25 Deamidation 5,263 ±0 SigFigSindri (talk | contribs) split §Principle from §Practical limitations [rollback]
  7. (diff | hist) 13:30 Chain of custody 5,157 ±0 NPOV_Nadia (talk | contribs) state what the certificate actually carries, field by field [rollback]
  8. (diff | hist) 09:43 Albumin binding half-life extension 6,399 ±0 ProglucagonPia (talk | contribs) split overlong sentence [rollback]
  9. (diff | hist) m b 05:28 Timeline of incretin therapeutics 4,460 ±0 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  10. (diff | hist) 03:11 AmbioPharm 7,964 +201 EndotoxinEd (talk | contribs) add the catalogue size and label it self-reported [rollback]

18 November 2025

  1. (diff | hist) 18:48 Lixisenatide 4,195 ±0 ComparisonCato (talk | contribs) ce per PP:MOS [rollback]
  2. (diff | hist) 18:22 Amino acid analysis 4,943 ±0 OralSemaOswin (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]
  3. (diff | hist) 16:11 Sigma-Aldrich (Shanghai) Trading 16,057 +902 GlossaryGleb (talk | contribs) add the standing talk-page note link to the banner [rollback]
  4. (diff | hist) 14:46 Shenzhen Hybio Pharmaceutical 11,068 +1,082 GroupBuyGalen (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  5. (diff | hist) m b 05:04 Amylin receptor agonist 5,245 ±0 ArchiveBot (talk | contribs) bot: add drug-class category [rollback]
  6. (diff | hist) m 04:27 Patent expiry and biosimilars 4,553 ±0 ReportReaderRilla (talk | contribs) attribute the enforcement statement to the published policy [rollback]
  7. (diff | hist) 03:44 Contract development and manufacturing organisation 5,011 ±0 CrudePeptidePearl (talk | contribs) clarify that "cold chain" without a logger is a claim, not a record [rollback]

17 November 2025

  1. (diff | hist) 21:33 Batch number 4,573 ±0 GroupBuyGalen (talk | contribs) expand §What a batch number cannot do [rollback]
  2. (diff | hist) 19:41 Flourishglobal Peptide Biotech 12,376 +226 BatchNumberBede (talk | contribs) ce, tighten prose [rollback]
  3. (diff | hist) 19:06 Hubei Jianxiang Bioscience 13,060 +1,005 Ref_Desk_Ron (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  4. (diff | hist) 15:03 Reconstitution of lyophilised peptides 5,761 ±0 CostPerMgCory (talk | contribs) fix the arithmetic in the worked reconstitution example [rollback]
  5. (diff | hist) m 14:42 Retatrutide 7,421 ±0 MazdutideMads (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  6. (diff | hist) 14:39 Lyophilisation 28,121 ±0 CDMO_Caradoc (talk | contribs) ce [rollback]
  7. (diff | hist) 04:07 Global access disparity 4,391 ±0 PatientPanelPru (talk | contribs) rm the specific plan recommendation; out of scope [rollback]
  8. (diff | hist) 01:16 Solid-phase peptide synthesis 5,359 ±0 SemaglutideSasha (talk | contribs) expand §Scale and its limits [rollback]

16 November 2025

  1. (diff | hist) m b 18:02 Vial 25,466 ±0 CategoryBot (talk | contribs) bot: normalise temperature formatting [rollback]
  2. (diff | hist) 12:41 Triple agonist 4,269 ±0 ApoB_Aurelio (talk | contribs) add CAS number, sourced [rollback]
  3. (diff | hist) m 12:29 Incretin effect 7,358 ±0 SatietySunniva (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  4. (diff | hist) 05:28 Contraindications of incretin therapy 4,993 ±0 LipidLedgerLou (talk | contribs) add the time course: most of these events are early and transient [rollback]
  5. (diff | hist) 04:35 Chinese Peptide Company 15,513 +220 PrimarySrcPatia (talk | contribs) fix a dangling clause [rollback]
  6. (diff | hist) 04:30 Purity claim inflation 5,660 ±0 Chromatokid (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]
  7. (diff | hist) 02:52 GL Biochem (Shanghai) 16,271 ±0 GroupBuyGalen (talk | contribs) state the city and province of the registered address [rollback]

15 November 2025

  1. (diff | hist) 18:42 MOTS-c 4,670 ±0 SemaxSevi (talk | contribs) de-orphan [rollback]
  2. (diff | hist) 18:15 PolyPeptide Group (Hangzhou) 10,342 +724 TrialsTabitha (talk | contribs) rm a duplicated category [rollback]
  3. (diff | hist) 18:11 Preparative HPLC purification 4,882 ±0 ColdChainCleo (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]
  4. (diff | hist) m 15:46 Receptor bias 4,477 ±0 HalfLifeHavel (talk | contribs) add the reference range with the assay it was established on [rollback]
  5. (diff | hist) 15:40 Peptide synthesis 5,649 ±0 FmocFrancis (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  6. (diff | hist) 08:29 Trifluoroacetate counterion 5,116 ±0 KarlFischerKit (talk | contribs) add the equilibration time to the gradient description [rollback]

14 November 2025

  1. (diff | hist) 16:27 Medutest 5,018 ±0 GlossaryGaspar (talk | contribs) expand §Comparability between services [rollback]
  2. (diff | hist) m b 03:00 Bacterial endotoxin test 5,317 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  3. (diff | hist) 00:51 Guangzhou JEEP Biotechnology 15,232 ±0 CheckSumChase (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]

13 November 2025

  1. (diff | hist) m b 21:23 Reconstitution calculator 8,662 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) 16:01 Janoshik Analytical 5,235 ±0 TrialsTabitha (talk | contribs) label the community tally as self-reported at this point of use as well [rollback]
  3. (diff | hist) 10:55 Talk:Vial 1,307 +108 Hedgerow_Hal (talk | contribs) /* The unmarked-vial paragraph is close to describing evasion */ reply
  4. (diff | hist) 07:21 GenScript Peptides 9,680 +747 SemaxSevi (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  5. (diff | hist) m 07:04 Dual incretin agonist 5,851 ±0 BacWaterBarnaby (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]

12 November 2025

  1. (diff | hist) 21:37 USP General Chapter 71 4,657 ±0 SigFigSindri (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) 21:36 Melanotan II 4,649 ±0 AnaesthesiaAoife (talk | contribs) add a hatnote separating this from the fragment of the same parent protein [rollback]
  3. (diff | hist) 21:09 Survodutide 5,445 ±0 EndpointEnid (talk | contribs) expand §Status and material sold under the name [rollback]
  4. (diff | hist) 20:05 ISO 9001 4,278 ±0 FootnoteFyfe (talk | contribs) add the cross-link to the legal-status-by-jurisdiction list [rollback]
  5. (diff | hist) m 15:56 ChinaPeptides 14,759 ±0 Chromatokid (talk | contribs) ce per PP:MOS [rollback]
  6. (diff | hist) m 11:44 Syringe dead space 11,156 +730 BacWaterBarnaby (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  7. (diff | hist) 10:15 AmbioPharm 7,763 +946 AnalyticalAnnie (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  8. (diff | hist) 09:44 Talk:GLP-1 receptor agonist 1,233 +109 Ref_Desk_Ron (talk | contribs) /* Requested move: → Glucagon-like peptide-1 receptor agonist */ reply
  9. (diff | hist) 09:37 Retention time 4,104 ±0 DiluentDiya (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  10. (diff | hist) 09:22 Talk:Vial 1,096 +146 NPOV_Nadia (talk | contribs) /* The unmarked-vial paragraph is close to describing evasion */ reply
  11. (diff | hist) 08:03 LEADER trial 4,799 ±0 PioneerPerdita (talk | contribs) flag the pooled analysis as post hoc [rollback]

11 November 2025

  1. (diff | hist) 23:59 Dulaglutide 5,490 ±0 ExenatideEzra (talk | contribs) add the molecular formula to the infobox [rollback]
  2. (diff | hist) 15:47 Talk:Vial 885 +370 GreyMarketGreer (talk | contribs) /* The unmarked-vial paragraph is close to describing evasion */ reply
  3. (diff | hist) 15:44 Lot traceability 5,317 ±0 VerifyVesna (talk | contribs) add the retest interval and what triggers one [rollback]
  4. (diff | hist) 12:24 Peptide stability table 6,798 ±0 Chromatokid (talk | contribs) close an unbalanced quotation mark [rollback]
  5. (diff | hist) 12:14 Talk:Vial 674 +317 NPOV_Nadia (talk | contribs) /* The unmarked-vial paragraph is close to describing evasion */ new section
  6. (diff | hist) 10:01 GLP-1 receptor agonist 11,264 ±0 LiraLotte (talk | contribs) convert a hard-coded date to the house format [rollback]
  7. (diff | hist) 07:49 Peptide harm reduction 4,800 ±0 NavboxNiko (talk | contribs) rm the specific plan recommendation; out of scope [rollback]
  8. (diff | hist) m 07:16 SinoPep 11,841 ±0 PrimarySrcPatia (talk | contribs) add the lead time for catalogue lines, as reported [rollback]
  9. (diff | hist) m b 04:16 Active pharmaceutical ingredient 4,569 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]

10 November 2025

  1. (diff | hist) m b 18:29 Research use only 7,990 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) m b 15:16 Shenzhen Hybio Pharmaceutical 9,986 +691 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  3. (diff | hist) 10:56 Trial data comparison 7,158 ±0 GastroparesisGwen (talk | contribs) space between number and unit per PP:MOS [rollback]
  4. (diff | hist) 06:44 Satiety signalling 5,593 ±0 NotabilityNoa (talk | contribs) correct the direction of the effect on gastric emptying [rollback]
  5. (diff | hist) m b 06:17 Peptide supply chain 8,410 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  6. (diff | hist) 05:49 Bacteriostatic water 4,652 ±0 ReportReaderRilla (talk | contribs) add the sharps-disposal cross-link [rollback]
  7. (diff | hist) 02:39 Reverse-phase HPLC 5,499 ±0 NewLabNell (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]

9 November 2025

  1. (diff | hist) 23:04 SELECT trial 5,171 ±0 LeaderLoic (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  2. (diff | hist) 14:46 Exenatide 5,754 ±0 LeanMassLars (talk | contribs) copyedit [rollback]
  3. (diff | hist) 13:46 Missed dose 5,277 ±0 BUD_Bertram (talk | contribs) fix a dangling clause [rollback]
  4. (diff | hist) m 10:16 Insulin syringe unit conversion 6,290 ±0 CDMO_Caradoc (talk | contribs) state the rounding rule the readout uses [rollback]
  5. (diff | hist) 02:14 Mass spectrometry 5,612 ±0 A1c_Alder (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  6. (diff | hist) 00:37 Body composition assessment 5,029 ±0 PanelPlannerPam (talk | contribs) alphabetise the see-also list [rollback]

8 November 2025

  1. (diff | hist) 23:18 Shanghai ERP Biotechnology 8,800 +451 COA_Colwyn (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  2. (diff | hist) 20:49 Resin cleavage 4,310 ±0 FreightFenna (talk | contribs) expand §Cocktails and scavengers [rollback]